EGFR and urinary bladder carcinoma: MiR-200 overexpression in bladder cancer cells increases their sensitivity towards the epidermal growth factor receptor (EGFR) inhibitors via regulating the expression of ERBB receptor feedback inhibitor 1 (ERRF1) (Adam et al., 2009).